SCHEMBL30568

SCHEMBL30568

C=CCOP(=O)(O)OO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174096 0.87 BTN3A1 (0.40)
SCHEMBL11677557 0.85 BTN3A1 (0.39)
Ammonia Solution, Strong SCHEMBL8023938 0.85 BTN3A1 (0.39)
SCHEMBL10625461 0.85 BTN3A1 (0.39)
Ethylene SCHEMBL28068723 0.85 BTN3A1 (0.39)
Benzene SCHEMBL11408934 0.81 TSHR (0.43)
Phosphonic Acid SCHEMBL10534004 0.79 BTN3A1 (0.35)
Allyl Pyrophosphate SCHEMBL1075959 0.79 BTN3A1 (0.59)
SCHEMBL9011393 0.79 BTN3A1 (0.35)
SCHEMBL30645 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732505-B1 OXIDATIVE TREATMENT AGENT, PARTICULARLY IN THE FORM OF A TRANSPARENT GEL WELLA AG (DE) 2008-12-24 EP claimed
US-5627166-A Activator for acaracide KAO CORPORATION (JP) 1997-05-06 US claimed
US-20240229036-A9 NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN KNC LABORATORIES CO., LTD. (JP) 2024-07-11 US disclosed
US-20240132893-A1 NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN KNC LABORATORIES CO., LTD. (JP) 2024-04-25 US disclosed
US-11958878-B2 Therapeutic agent for glycogen storage disease type IA DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-04-16 US disclosed
EP-4299743-A1 NUCLEIC ACID MEDICINE EXPRESSING SPLICING VARIANT OF MYOSTATIN KNC Laboratories Co., Ltd. (JP) 2024-01-03 EP disclosed
US-20230272403-A1 ANTISENSE OLIGONUCLEOTIDE INDUCING EXON SKIPPING OF ANGIOTENSIN CONVERTING ENZYME 2 GENE KNC LABORATORIES CO., LTD. (JP) 2023-08-31 US disclosed
EP-4201484-A1 ANTISENSE NUCLEIC ACID INDUCING EXON SKIPPING OF ANGIOTENSIN CONVERTING ENZYME 2 GENE KNC Laboratories Co., Ltd. (JP) 2023-06-28 EP disclosed
CN-115976028-A Remedies for glycogen disease type Ia 第一三共株式会社 2023-04-18 CN disclosed
EP-3146970-B1 NUCLEIC ACID DRUG FOR INDUCING SKIPPING OF VARIANT EXON OF CD44 GENE AND INCREASING EXPRESSION OF NORMAL TYPE CD44 MRNA KNC LABORATORIES CO LTD (JP) 2022-11-02 EP disclosed
US-20220220478-A1 NUCLEIC ACID DRUG SUPPRESSING PRODUCTION OF MYOSTATIN GENE MRNA KNC LABORATORIES CO., LTD. (JP) 2022-07-14 US disclosed
EP-1068006-A1 DISPERSANTS THE LUBRIZOL CORPORATION (US) 2001-01-17 EP disclosed
EP-0958041-A1 DISPERSANTS ZENECA LIMITED (GB) 1999-11-24 EP disclosed
WO-1999049963-A1 DISPERSANTS AVECIA LIMITED (GB) 1999-10-07 WO disclosed
WO-1998019784-A1 DISPERSANTS ZENECA LIMITED (GB) 1998-05-14 WO disclosed
EP-0101307-B1 AQUEOUS SELF-CURING POLYMERIC BLENDS THE GLIDDEN COMPANY (formerly known as ATKEMIX EIGHT INC.) (US) 1989-05-24 EP disclosed
US-4795574-A HYDRATED LIME AND SODIUM BICARBONATE NALCO CHEMICAL COMPANY (US) 1989-01-03 US disclosed
EP-0101307-A2 Aqueous self-curing polymeric blends THE GLIDDEN COMPANY (formerly known as ATKEMIX EIGHT INC.) (US) 1984-02-22 EP disclosed
US-4195139-A PLASTICS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-03-25 US disclosed
US-4094685-A LATEX, ENCAPSULATION POLYMERICS, INC. (US) 1978-06-13 US disclosed